BRCA1 and breast carcinoma: This places the receptor phenotypes of the MINAS breast cancers intermediate between that of BRCA2 only and BRCA1 only breast cancers, and would be consistent with an independent rather than synergistic effect in BRCA1/BRCA2 MINAS.